IgA nephropathy screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{IgA nephropathy}}
{{IgA nephropathy}}
{{CMG}}; {{APM}} {{AE}}{{OO}}
{{CMG}}; {{APM}} {{AE}}{{OO}}
== Overview ==
According to the National Kidney Foundation guidelines for [[glomerulonephritis]], [[screening]] is currently not recommended for IgA nephropathy.<ref name="pmid22895519" />
==Screening==
==Screening==
According to the National Kidney Foundation guidelines for [[glomerulonephritis]]<ref name="pmid22895519">{{cite journal| author=Radhakrishnan J, Cattran DC| title=The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. | journal=Kidney Int | year= 2012 | volume= 82 | issue= 8 | pages= 840-56 | pmid=22895519 | doi=10.1038/ki.2012.280 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22895519 }} </ref>, [[screening]] is currently not recommended for IgA nephropathy.
According to the National Kidney Foundation guidelines for [[glomerulonephritis]], [[screening]] is currently not recommended for IgA nephropathy.<ref name="pmid22895519">{{cite journal| author=Radhakrishnan J, Cattran DC| title=The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. | journal=Kidney Int | year= 2012 | volume= 82 | issue= 8 | pages= 840-56 | pmid=22895519 | doi=10.1038/ki.2012.280 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22895519 }} </ref>


==References==
==References==

Revision as of 17:46, 18 July 2018

IgA nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating IgA nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

IgA nephropathy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of IgA nephropathy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on IgA nephropathy screening

CDC on IgA nephropathy screening

IgA nephropathy screening in the news

Blogs on IgA nephropathy screening

Directions to Hospitals Treating IgA nephropathy

Risk calculators and risk factors for IgA nephropathy screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]

Overview

According to the National Kidney Foundation guidelines for glomerulonephritis, screening is currently not recommended for IgA nephropathy.[1]

Screening

According to the National Kidney Foundation guidelines for glomerulonephritis, screening is currently not recommended for IgA nephropathy.[1]

References

  1. 1.0 1.1 Radhakrishnan J, Cattran DC (2012). "The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient". Kidney Int. 82 (8): 840–56. doi:10.1038/ki.2012.280. PMID 22895519.

Template:WHTemplate:WS